img

Global COPD Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global COPD Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of death in the world.
COPD Therapeutics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global COPD Therapeutics market is projected to reach US$ 849.7 million in 2029, increasing from US$ 525 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Adult and Child are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global COPD Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
AstraZeneca
Theravance Biopharma
Mylan
Segment by Type
Bronchodilators
Inhaled Corticosteroids
Other

Segment by Application


Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the COPD Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, COPD Therapeutics introduction, etc. COPD Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of COPD Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of COPD Therapeutics
1.1 COPD Therapeutics Market Overview
1.1.1 COPD Therapeutics Product Scope
1.1.2 COPD Therapeutics Market Status and Outlook
1.2 Global COPD Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global COPD Therapeutics Market Size by Region (2018-2029)
1.4 Global COPD Therapeutics Historic Market Size by Region (2018-2024)
1.5 Global COPD Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, COPD Therapeutics Market Size (2018-2029)
1.6.1 North America COPD Therapeutics Market Size (2018-2029)
1.6.2 Europe COPD Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific COPD Therapeutics Market Size (2018-2029)
1.6.4 Latin America COPD Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa COPD Therapeutics Market Size (2018-2029)
2 COPD Therapeutics Market by Type
2.1 Introduction
2.1.1 Bronchodilators
2.1.2 Inhaled Corticosteroids
2.1.3 Other
2.2 Global COPD Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global COPD Therapeutics Historic Market Size by Type (2018-2024)
2.2.2 Global COPD Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America COPD Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe COPD Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific COPD Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America COPD Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa COPD Therapeutics Revenue Breakdown by Type (2018-2029)
3 COPD Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Adult
3.1.2 Child
3.2 Global COPD Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global COPD Therapeutics Historic Market Size by Application (2018-2024)
3.2.2 Global COPD Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America COPD Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe COPD Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific COPD Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America COPD Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa COPD Therapeutics Revenue Breakdown by Application (2018-2029)
4 COPD Therapeutics Competition Analysis by Players
4.1 Global COPD Therapeutics Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2022)
4.3 Date of Key Players Enter into COPD Therapeutics Market
4.4 Global Top Players COPD Therapeutics Headquarters and Area Served
4.5 Key Players COPD Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 COPD Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline COPD Therapeutics Products, Services and Solutions
5.1.4 GlaxoSmithKline COPD Therapeutics Revenue (US$ Million) & (2018-2024)
5.1.5 GlaxoSmithKline Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca COPD Therapeutics Products, Services and Solutions
5.2.4 AstraZeneca COPD Therapeutics Revenue (US$ Million) & (2018-2024)
5.2.5 AstraZeneca Recent Developments
5.3 Theravance Biopharma
5.3.1 Theravance Biopharma Profile
5.3.2 Theravance Biopharma Main Business
5.3.3 Theravance Biopharma COPD Therapeutics Products, Services and Solutions
5.3.4 Theravance Biopharma COPD Therapeutics Revenue (US$ Million) & (2018-2024)
5.3.5 Mylan Recent Developments
5.4 Mylan
5.4.1 Mylan Profile
5.4.2 Mylan Main Business
5.4.3 Mylan COPD Therapeutics Products, Services and Solutions
5.4.4 Mylan COPD Therapeutics Revenue (US$ Million) & (2018-2024)
5.4.5 Mylan Recent Developments
6 North America
6.1 North America COPD Therapeutics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe COPD Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific COPD Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America COPD Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa COPD Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 COPD Therapeutics Market Dynamics
11.1 COPD Therapeutics Industry Trends
11.2 COPD Therapeutics Market Drivers
11.3 COPD Therapeutics Market Challenges
11.4 COPD Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market COPD Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global COPD Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global COPD Therapeutics Market Size Share by Region (2018-2024)
Table 4. Global COPD Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global COPD Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global COPD Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global COPD Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global COPD Therapeutics Revenue Market Share by Type (2018-2024)
Table 9. Global COPD Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global COPD Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America COPD Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America COPD Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe COPD Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe COPD Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific COPD Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific COPD Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America COPD Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America COPD Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa COPD Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa COPD Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global COPD Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global COPD Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global COPD Therapeutics Revenue Market Share by Application (2018-2024)
Table 24. Global COPD Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global COPD Therapeutics Revenue Market Share by Application (2024-2029)
Table 26. North America COPD Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America COPD Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe COPD Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe COPD Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific COPD Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific COPD Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America COPD Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America COPD Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa COPD Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa COPD Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global COPD Therapeutics Revenue (US$ Million) by Players (2018-2024)
Table 37. Global COPD Therapeutics Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2022)
Table 39. Date of Key Players Enter into COPD Therapeutics Market
Table 40. Global COPD Therapeutics Key Players Headquarters and Area Served
Table 41. COPD Therapeutics Product Solution and Service
Table 42. Global COPD Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. GlaxoSmithKline Basic Information List
Table 45. GlaxoSmithKline Description and Business Overview
Table 46. GlaxoSmithKline COPD Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in COPD Therapeutics Business of GlaxoSmithKline (2018-2024)
Table 48. GlaxoSmithKline Recent Developments
Table 49. AstraZeneca Basic Information List
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca COPD Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in COPD Therapeutics Business of AstraZeneca (2018-2024)
Table 53. AstraZeneca Recent Developments
Table 54. Theravance Biopharma Basic Information List
Table 55. Theravance Biopharma Description and Business Overview
Table 56. Theravance Biopharma COPD Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in COPD Therapeutics Business of Theravance Biopharma (2018-2024)
Table 58. Theravance Biopharma Recent Developments
Table 59. Mylan Basic Information List
Table 60. Mylan Description and Business Overview
Table 61. Mylan COPD Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in COPD Therapeutics Business of Mylan (2018-2024)
Table 63. Mylan Recent Developments
Table 64. North America COPD Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 65. North America COPD Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 66. Europe COPD Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 67. Europe COPD Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 68. Asia-Pacific COPD Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 69. Asia-Pacific COPD Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 70. Asia-Pacific COPD Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 71. Asia-Pacific COPD Therapeutics Market Share by Region (2018-2024)
Table 72. Asia-Pacific COPD Therapeutics Market Share by Region (2024-2029)
Table 73. Latin America COPD Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 74. Latin America COPD Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 75. Latin America COPD Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 76. Middle East & Africa COPD Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 77. Middle East & Africa COPD Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 78. Middle East & Africa COPD Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 79. COPD Therapeutics Market Trends
Table 80. COPD Therapeutics Market Drivers
Table 81. COPD Therapeutics Market Challenges
Table 82. COPD Therapeutics Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COPD Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global COPD Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global COPD Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global COPD Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America COPD Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe COPD Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific COPD Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America COPD Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa COPD Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Bronchodilators
Figure 11. Global Bronchodilators Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Inhaled Corticosteroids
Figure 13. Global Inhaled Corticosteroids Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Other
Figure 15. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global COPD Therapeutics Market Size Share by Type: 2022 & 2029
Figure 17. North America COPD Therapeutics Revenue Market Share by Type (2018-2029)
Figure 18. Europe COPD Therapeutics Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific COPD Therapeutics Revenue Market Share by Type (2018-2029)
Figure 20. Latin America COPD Therapeutics Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa COPD Therapeutics Revenue Market Share by Type (2018-2029)
Figure 22. Adult Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Child Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Global COPD Therapeutics Market Size Share by Application: 2022 & 2029
Figure 25. North America COPD Therapeutics Revenue Market Share by Application (2018-2029)
Figure 26. Europe COPD Therapeutics Revenue Market Share by Application (2018-2029)
Figure 27. Asia-Pacific COPD Therapeutics Revenue Market Share by Application (2018-2029)
Figure 28. Latin America COPD Therapeutics Revenue Market Share by Application (2018-2029)
Figure 29. Middle East and Africa COPD Therapeutics Revenue Market Share by Application (2018-2029)
Figure 30. COPD Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players COPD Therapeutics Market Share in 2022
Figure 32. North America COPD Therapeutics Market Share by Country (2018-2029)
Figure 33. United States COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 34. Canada COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 35. Germany COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 36. France COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 37. U.K. COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 38. Italy COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. Russia COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. Nordic Countries COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 41. Asia-Pacific COPD Therapeutics Market Share by Region (2018-2029)
Figure 42. China COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 43. Japan COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. South Korea COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 45. Southeast Asia COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 46. India COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 47. Australia COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 48. Latin America COPD Therapeutics Market Share by Country (2018-2029)
Figure 49. Mexico COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 50. Brazil COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa COPD Therapeutics Market Share by Country (2018-2029)
Figure 52. Turkey COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 54. UAE COPD Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report